Verona Pharma plc·4

Nov 3, 8:09 PM ET

Poll Claire 4

4 · Verona Pharma plc · Filed Nov 3, 2023

Insider Transaction Report

Form 4
Period: 2023-11-01
Poll Claire
General Counsel
Transactions
  • Tax Payment

    Ordinary Shares

    2023-11-01$1.74/sh173,904$303,2541,843,487 total
  • Gift

    Ordinary Shares

    2023-11-01196,0961,647,391 total
  • Gift

    Ordinary Shares

    2023-11-01+196,0961,060,328 total(indirect: By Trust)
Footnotes (5)
  • [F1]Reported securities are represented by American Depositary Shares ("ADSs"), each of which represents eight (8) Ordinary Shares of the Issuer.
  • [F2]Represents the number of Ordinary Shares withheld to satisfy the tax withholding obligation in connection with the vesting of certain previously reported Restricted Share Units.
  • [F3]The price reported represents the closing price of the Issuer's ADSs on the Nasdaq Stock Market LLC on October 31, 2023 divided by eight (8).
  • [F4]Consists of (i) 1,301,672 Ordinary Shares underlying Restricted Share Units, each of which represents a contingent right to receive one (1) Ordinary Share of the Issuer (which are represented by 162,709 ADSs); (ii) 345,712 Ordinary Shares underlying 43,214 ADSs and (iii) 7 Ordinary Shares.
  • [F5]Held by a family trust of which (a) the Reporting Person and spouse are trustees and (b) the Reporting Person and members of her immediate family are the sole beneficiaries of the trust.

Documents

1 file
  • 4
    tm2329834-3_4seq1.xmlPrimary

    OWNERSHIP DOCUMENT